INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 260 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,209,992 | +4.3% | 1,262,188 | +12.3% | 0.01% | +20.0% |
| Q2 2023 | $46,240,251 | -26.8% | 1,124,246 | +2.2% | 0.01% | -37.5% |
| Q1 2023 | $63,128,572 | +105857.8% | 1,099,609 | +3.5% | 0.01% | 0.0% |
| Q4 2022 | $59,579 | -99.9% | 1,062,589 | +5.4% | 0.01% | +33.3% |
| Q3 2022 | $42,713,000 | -20.6% | 1,008,351 | +1.2% | 0.01% | -25.0% |
| Q2 2022 | $53,828,000 | -17.4% | 996,265 | -1.7% | 0.01% | 0.0% |
| Q1 2022 | $65,151,000 | -3.4% | 1,013,878 | +0.7% | 0.01% | 0.0% |
| Q4 2021 | $67,421,000 | +3.7% | 1,006,447 | +6.0% | 0.01% | -11.1% |
| Q3 2021 | $65,002,000 | +0.9% | 949,216 | +0.6% | 0.01% | 0.0% |
| Q2 2021 | $64,391,000 | +0.8% | 943,607 | +2.0% | 0.01% | -10.0% |
| Q1 2021 | $63,885,000 | +9.1% | 924,670 | +2.5% | 0.01% | 0.0% |
| Q4 2020 | $58,577,000 | +45.1% | 902,301 | +5.6% | 0.01% | +25.0% |
| Q3 2020 | $40,360,000 | -3.4% | 854,746 | -3.9% | 0.01% | -11.1% |
| Q2 2020 | $41,785,000 | +6.2% | 889,244 | +0.9% | 0.01% | -10.0% |
| Q1 2020 | $39,362,000 | -60.1% | 881,206 | -47.9% | 0.01% | 0.0% |
| Q4 2019 | $98,556,000 | +97.2% | 1,691,078 | +103.2% | 0.01% | -16.7% |
| Q3 2019 | $49,982,000 | +8.1% | 832,075 | +0.5% | 0.01% | +9.1% |
| Q2 2019 | $46,246,000 | +7.8% | 828,042 | +7.5% | 0.01% | 0.0% |
| Q1 2019 | $42,911,000 | -35.0% | 770,132 | -47.4% | 0.01% | +10.0% |
| Q4 2018 | $65,974,000 | +44.8% | 1,462,862 | +111.5% | 0.01% | -23.1% |
| Q3 2018 | $45,568,000 | +5.8% | 691,794 | +3.5% | 0.01% | 0.0% |
| Q2 2018 | $43,067,000 | +31.2% | 668,639 | +12.7% | 0.01% | +18.2% |
| Q1 2018 | $32,819,000 | +21.7% | 593,050 | +5.3% | 0.01% | +22.2% |
| Q4 2017 | $26,964,000 | -4.8% | 563,397 | +0.5% | 0.01% | -10.0% |
| Q3 2017 | $28,310,000 | -2.5% | 560,818 | +5.3% | 0.01% | -9.1% |
| Q2 2017 | $29,029,000 | +29.6% | 532,556 | +0.2% | 0.01% | +22.2% |
| Q1 2017 | $22,401,000 | +4.9% | 531,732 | +113.6% | 0.01% | -10.0% |
| Q4 2016 | $21,361,000 | +16.9% | 248,995 | +12.5% | 0.01% | +11.1% |
| Q3 2016 | $18,277,000 | +11.6% | 221,412 | +7.9% | 0.01% | 0.0% |
| Q2 2016 | $16,377,000 | +19.7% | 205,287 | +1.1% | 0.01% | +28.6% |
| Q1 2016 | $13,684,000 | +3.1% | 203,148 | +3.7% | 0.01% | -12.5% |
| Q4 2015 | $13,276,000 | +24.8% | 195,878 | +9.7% | 0.01% | +33.3% |
| Q3 2015 | $10,634,000 | -2.3% | 178,574 | +10.6% | 0.01% | 0.0% |
| Q2 2015 | $10,879,000 | +12.4% | 161,496 | +2.8% | 0.01% | 0.0% |
| Q1 2015 | $9,682,000 | +19.7% | 157,058 | +5.3% | 0.01% | +20.0% |
| Q4 2014 | $8,088,000 | +20.0% | 149,160 | +9.9% | 0.01% | +25.0% |
| Q3 2014 | $6,740,000 | +6.1% | 135,785 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $6,354,000 | +10.9% | 135,032 | +8.4% | 0.00% | 0.0% |
| Q1 2014 | $5,731,000 | -0.2% | 124,620 | +3.5% | 0.00% | 0.0% |
| Q4 2013 | $5,744,000 | +32.1% | 120,400 | +11.4% | 0.00% | +33.3% |
| Q3 2013 | $4,348,000 | +11.0% | 108,037 | +1.0% | 0.00% | 0.0% |
| Q2 2013 | $3,917,000 | – | 106,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |